Precigen (PGEN) FCF Margin (2012 - 2026)
Precigen (PGEN) posted quarterly FCF Margin of 189.34% for Q1 2026, up 107442.0% year-over-year from N/an in Q1 2025, and up 36.56% quarter-over-quarter from 298.47% in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) FCF Margin (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported FCF Margin for 15 consecutive years, with 189.34% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin rose 107442.0% year-over-year to 189.34%; the TTM figure through Mar 2026 stood at 355.97% (up 80980.0% YoY), while the FY2025 annual figure was 927.57%, up 81801.0% from the prior year.
- FCF Margin grew to 189.34% in Q1 2026 per PGEN's latest filing, from 298.47% in the prior quarter.
- Across five years, FCF Margin topped out at 106.22% in Q4 2022 and bottomed at 2361500.0% in Q3 2024.
- Historically, FCF Margin has averaged 256342.49% across 5 years, with a median of 1084.6% in 2023.
- Annual changes were most pronounced in 2023 — FCF Margin tumbled 172420546 bps — and 2025, when it soared 235823121 bps.
- Precigen's FCF Margin stood at 106.22% in 2022, then tumbled by 1315 bps to 1289.98% in 2023, then surged by 98 bps to 27.86% in 2024, then plunged by 971 bps to 298.47% in 2025, then soared by 37 bps to 189.34% in 2026.
- Business Quant data shows PGEN's FCF Margin at 189.34% in Q1 2026, 298.47% in Q4 2025, and 3268.79% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | -33.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -33.11% |
| Mar 31, 2026 | -189.60% |
| Dec 31, 2025 | -514.30% |
| Sep 30, 2025 | -1,008.15% |
| Jun 30, 2025 | -2,301.29% |
| Mar 31, 2025 | -1,281.95% |
| Dec 31, 2024 | -779.08% |
| Sep 30, 2024 | -2,477.96% |
| Jun 30, 2024 | -3,546.72% |
| Mar 31, 2024 | -1,731.55% |
| Dec 31, 2023 | -1,346.09% |
| Sep 30, 2023 | -1,270.85% |
| Jun 30, 2023 | -898.08% |
| Mar 31, 2023 | -1,001.73% |
| Dec 31, 2022 | -876.29% |
| Sep 30, 2022 | -151.82% |
| Jun 30, 2022 | -301.31% |
| Mar 31, 2022 | -369.35% |
| Dec 31, 2021 | -471.28% |
| Sep 30, 2021 | -578.70% |